<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Petrology of Indus River sands: a key to interpret erosion history of the Western Himalayan Syntaxis
2
Petrology of iron-rich magmatic segregations associated with strongly peraluminous trondhjemite in the Cornucopia stock, northeastern Oregon
3
Petrology of kamafugites and kimberlites from the Alto Paranaíba Alkaline Province, Minas Gerais, Brazil
4
Petrology of Lasail plutonic complex, northern Oman ophiolite, Oman: An example of arc-like magmatism associated with ophiolite detachment
5
Petrology of mafic and ultramafic intrusions from the Portneuf–Mauricie Domain, Grenville Province, Canada: Implications for plutonic complexes in a Proterozoic island arc
6
Petrology of mafic and ultramafic layered rocks from the Jaboncillo Valley, Sierra de Valle Fértil, Argentina: Implications for the evolution of magmas in the lower crust of the Famatinian arc
7
Petrology of mafic lavas within the Onega plateau, central Karelia: evidence for 2.0 Ga plume-related continental crustal growth in the Baltic Shield
8
Petrology of melilite-bearing rocks from the Montefiascone Volcanic Complex (Roman Magmatic Province): new insights into the ultrapotassic volcanism of Central Italy
9
Petrology of Nile River sands (Ethiopia and Sudan): Sediment budgets and erosion patterns
10
Petrology of Ocellar Lamprophyres in South Delhi Fold Belt, Danva, Sirohi District, Rajasthan, India
11
Petrology of rocks formed by interaction of mafic magmas and high-grade metamorphic rocks at Suya Taco area, northern Sierra de Comechingones, Argentina
12
Petrology of sapphirine granulite and associated sodic gneisses from the Indian Head Range, Newfoundland
13
Petrology of spinel peridotite xenoliths from northeastern Brazil: lithosphere with a high geothermal gradient imparted by Fernando de Noronha plume
14
Petrology of the 1991–1995 eruption at Unzen: effusion pulsation and groundmass crystallization
15
Petrology of the 1998–2000 products of Volcán de Colima, México
16
Petrology of the Basic Granulites from Kodaikanal, South India
17
Petrology of the Betulia Igneous Complex, Cauca, Colombia
18
Petrology of the bimodal Cenozoic volcanism of the Kapsiki plateau (northernmost Cameroon, Central Africa)
19
Petrology of the Cenozoic volcanism in the Upper Benue valley, northern Cameroon (Central Africa)
20
Petrology of the Coyaguayma ignimbrite, northern Puna of Argentina: Origin and evolution of a peraluminous high-SiO2 rhyolite magma
21
Petrology of the Easter microplate region in the South Pacific
22
Petrology of the eclogites from western Tasmania: Insights into the Cambro-Ordovician evolution of the paleo-Pacific margin of Gondwana
23
Petrology of the granitoid intrusions in the Shalair Valley area, northeastern Iraq
24
Petrology of the Hegenshan ophiolite and its implication for the tectonic evolution of northern China
25
Petrology of the hypabyssal kimberlite of the Kroonstad group II kimberlite (orangeite) cluster, South Africa: Evolution of the magma within the cluster
26
PETROLOGY OF THE INJANA FORMATION (UPPER MIOCENE)AT ZAWITA, AMADIYA AND ZAKHO AREA, NORTHERN IRAQ
27
Petrology of the Luingo caldera (SE margin of the Puna plateau): A middle Miocene window of the arc–back arc configuration
28
Petrology of the Mesoarchean Rio Maria suite and the discrimination of sanukitoid series
29
Petrology of the Miocene igneous rocks in the Altar region, main Cordillera of San Juan, Argentina. A geodynamic model within the context of the Andean flat-slab segment and metallogenesis
30
Petrology of the Mio-Pliocene volcanism to the North and East of Ngaoundéré (Adamawa, Cameroon)
31
Petrology of the most recent ultrapotassic magmas from the Roman Province (Central Italy)
32
Petrology of the Namib Sand Sea: Long-distance transport and compositional variability in the wind-displaced Orange Delta
33
Petrology of the Nohi Rhyolite and its related granitoids: A Late Cretaceous large silicic igneous field in central Japan
34
Petrology of the Precambrian Mafic Rocks of Katekalyan Area, Bastar District, Madhya Pradesh, India
35
Petrology of the Rabaul Caldera area, Papua New Guinea
36
Petrology of the Renard igneous bodies: host rocks for diamond in the northern Otish Mountains region, Quebec
37
Petrology of titanian clinohumite and olivine at the high-pressure breakdown of antigorite serpentinite to chlorite harzburgite (Almirez Massif, S. Spain)
38
Petrology of two continental alkaline intraplate series at Emi Koussi volcano, Tibesti, Chad
39
Petrology of two diamondiferous eclogite xenoliths from the Lahtojoki kimberlite pipe, eastern Finland
40
Petrology of ultrahigh-pressure eclogites from the ZK703 drillhole in the Donghai, eastern China
41
Petrology of ultramafic lamprophyres from the Beaver Lake area of Eastern Antarctica and their relation to the breakup of Gondwanaland
42
Petrology of ultramafic xenoliths in Cenozoic alkaline rocks of northern Madagascar (Nosy Be Archipelago)
43
Petrology of volcanic products younger than 42 ka on the Lipari–Vulcano complex (Aeolian Islands, Italy): an example of volcanism controlled by tectonics
44
Petrology, geochemistry and genesis of rift-related carbonatites of Ambadungar, India
45
Petrology, geochemistry and geodynamic implications of Jurassic island arc magmatism as revealed by mafic volcanic rocks in the Mesozoic low-grade sequence, eastern Rhodope, Bulgaria
46
Petrology, geochemistry and geodynamic setting of Proterozoic igneous suites of the Orَs fold belt (Borborema Province, Northeast Brazil)
47
Petrology, geochemistry and isotopic ages of eclogites from the Dulan UHPM Terrane, the North Qaidam, NW China
48
Petrology, geochemistry and paleomagnetism of the earliest magmatic rocks of Deccan Volcanic Province, Kutch, Northwest India
49
Petrology, geochemistry and ReOs isotopes of peridotite xenoliths from Maguan, Yunnan Province: Implications for the Cenozoic mantle replacement in southwestern China
50
Petrology, geochemistry and Re–Os isotopes of peridotite xenoliths from Yantai, Shandong Province: Evidence for Phanerozoic lithospheric mantle beneath eastern North China Craton
51
Petrology, geochemistry and Sr–Nd isotopes of the Trindade and Martin Vaz volcanic rocks (Southern Atlantic Ocean)
52
Petrology, geochemistry and Sr–Nd–Pb isotopes of the volcanic rocks from Pico Island—Azores (Portugal)
53
Petrology, geochemistry and tectonic setting intrusive massives of Baft ophiolitic – melange, Southeast of Kerman, Iran
54
Petrology, geochemistry and tectonic significance of Palaeoproterozoic alkaline lamprophyres from the Jungel Valley, Mahakoshal supracrustal belt, Central India
55
PETROLOGY, GEOCHEMISTRY AND TECTONICAL ENVIRONMENT OF THE SHALAIR METAMORPHIC ROCK GROUP AND KATAR RASH VOLCANIC GROUP, SHALAIR VALLY AREA, NORTHEASTERN IRAQ
56
Petrology, Geochemistry and Tectonomagmatic Evolution of Hezar Igneous Complex (Rayen- South of Kerman- Iran): the First Description of an Arc Remnant of the Neotethyan Subduction Zone
57
Petrology, geochemistry and U–Pb geochronology of the Betic Ophiolites: Inferences for Pangaea break-up and birth of the westernmost Tethys Ocean
58
Petrology, geochemistry and zircon U–Pb and Lu–Hf isotopes of the Cretaceous dykes in the central North China Craton: Implications for magma genesis and gold metallogeny
59
Petrology, geochemistry, and geochronology of Paleoproterozoic volcanic and granitic rocks (1.89–1.88 Ga) of the Pitinga Province, Amazonian Craton, Brazil
60
Petrology, geochemistry, and geochronology of the post-collisional Triassic mangerite and syenite in the Gwangcheon area, Hongseong Belt, South Korea
61
Petrology, geochemistry, and geochronology of trondhjemites from the Qori Complex, Neyriz, Iran
62
Petrology, geochemistry, and Na metasomatism of Triassic-Jurassic non-marine clastic sediments in the Newark, Hartford, and Deerfield rift basins, northeastern USA
63
Petrology, geochemistry, and petrogenesis of mafic dykes from the Kermanshah Ophiolite in Sahneh-Harsin area of Western Iran
64
Petrology, Geochemistry, Petrogenesis and Reactivation of Volcanic Tuffs at Dair El-Kahif Area, NE-Jordan
65
Petrology, geochemistry, S, Cl and F abundances, and S oxidation state of sideromelane glass shards from Pleistocene ash layers north and south of Gran Canaria (ODP Leg 157)
66
Petrology, geochronology and Sr–Nd isotopic geochemistry of the Konso pluton, south-western Ethiopia: implications for transition from convergence to extension in the Mozambique Belt
67
Petrology, isotope geochemistry and chemical budgets of oceanic gabbros-seawater interactions in the Equatorial Atlantic
68
Petrology, major and trace element geochemistry, geochronology, and isotopic composition of granitic intrusions from the vicinity of the Bosumtwi impact crater, Ghana
69
Petrology, mineral and isotope geochemistry of the Sondalo gabbroic complex (Central Alps, Northern Italy): implications for the origin of post-Variscan magmatism
70
Petrology, mineral chemistry and Sr–Nd–Pb isotopic compositions of granitoids in the central Menderes metamorphic core complex: Constraints on the evolution of Aegean lithosphere slab
71
Petrology, mineral chemistry, and exploration significance of Fe-sulfides from the metal dispersion halo surrounding the Cadjebut Znsingle bondPb MVT deposit, Western Australia
72
Petrology, Mineralogy and Diagenesis of the Rus and Jil Formations (l- Eocene) in Najif and Samawa areas, Southern Iraq
73
Petrology, mineralogy and geochemistry of oxide minerals in polymict xenoliths from the Bultfontein kimberlites, South Africa: implication for low bulk-rock oxygen isotopic ratios
74
Petrology, Origin and Metamorphic History of Proterozoic-aged Granulites of the Natal Metamorphic Province, Southeastern Africa
75
Petrology, structural setting, timing, and geochemistry of Cretaceous volcanic rocks in eastern Mongolia: Constraints on their tectonic origin
76
Petrology, structure and tectonic significance of the Tuclame banded schists in the Sierras Pampeanas of Cَrdoba and its relationship with the metamorphic basement of northwestern Argentina
77
Petrol—something nasty in the woodshed? A review of gasoline-related burns in a British burns unit
78
Petromagnetic characteristics of Cameroon Line volcanic rocks
79
PETROMAP: MS-DOS software package for quantitative processing of X-ray maps of zoned minerals
80
Petro-mineralogy and geochemistry as tools of provenance analysis on archaeological pottery: Study of Inka Period ceramics from Paria, Bolivia
81
Petronella Clarke
82
Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography
83
Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography
84
Petrophysical analysis of regional-scale thermal properties for improved simulations of geothermal installations and basin-scale heat and fluid flow
85
Petro-physical Analysis of Well Logs for Reservoir Evaluation: A Case Study of Well 1 and 2 of the ‘Ictorian’ Field in the Niger Delta Basin
86
Petrophysical and consolidation behavior of mass transport deposits from the northern Gulf of Mexico, IODP Expedition 308
87
Petrophysical and durability tests on sandstones for the evaluation of their quality as building stones using Analytical Hierarchy Process (AHP)
88
Petrophysical and rock-mechanics effects of CO2 injection for enhanced oil recovery: Experimental study on chalk from South Arne field, North Sea
89
Petrophysical characterization of Chinese coal cores with heat treatment by nuclear magnetic resonance
90
Petrophysical characterization of coals by low-field nuclear magnetic resonance (NMR)
91
Petrophysical Charaterization of the Kwale Field Reservoir Sands (OML 60) from Wire-line Logs, Niger Delta, Nigeria
92
Petrophysical Constraints on Deformation Styles in Aztec Sandstone, Southern Nevada, USA
93
Petrophysical data for integrated flow modeling
94
Petrophysical data prediction from seismic attributes using committee fuzzy inference system
95
Petrophysical databases for ground characterisation: design concepts and considerations
96
Petrophysical Evaluation of Bangestan Group Formations in an Iranian Oil Field Document Type : Research Paper
97
Petrophysical evaluation of low-resistivity sandstone reservoirs with nuclear magnetic resonance log
98
Petrophysical Evaluation of Reservoir in A Selected Well (Z) in an Onshore Oil Field (X) in the Niger Delta Basin, Nigeria using Wireline Logs
99
Petrophysical Evaluation of Reservoir Sand Bodies in Kwe Field Onshore Eastern Niger Delta
100
Petrophysical laboratory measurements for basin and reservoir evaluation
101
Petrophysical Properties and Reservoir Modeling of Mishrif Formation at Amara Oil Field, Southeast Iraq
102
Petrophysical properties of bioclastic platform carbonates: implications for porosity controls during burial
103
Petrophysical properties of porous medium from Petrographic Image Analysis data
104
Petrophysical Properties of the Kahasib Formation in Missan Region, South Iraq
105
Petros D. Karkos, Spiros P. Potamianos, Maria T. Apostolidis, Giorgios Kekes
106
Petrosal approach: The avenue to the cerebellopontine angle and petrous apex
107
Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp Original Research Article
108
Petrosectomies for invasive tumours: surgery and reconstruction
109
Petrosia testudinaria as a biomarker for metal contamination at Gulf of Mannar, southeast coast of India
110
Petrosiols A–E, neurotrophic diyne tetraols isolated from the Okinawan sponge Petrosia strongylata
111
Petrotectonic evolution of the high- to ultrahigh-pressure Maksyutov Complex, Karayanova area, south Ural Mountains: structural and oxygen isotope constraints
112
Petrotetrayndiol A induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells through cytochrome c-mediated activation of caspases
113
Petrous apicitis in a child: computed tomography and magnetic resonance imaging findings
114
Petrov–Galerkin and discontinuous-Galerkin methods for time-domain and frequency-domain electromagnetic simulations
115
Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model
116
Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model
117
Petrov-Galerkin finite element method for gas–liquid two-phase flow based on an incompressible two-fluid model Original Research Article
118
Petrov-Galerkin finite element method for solving the MRLW equation
119
Petrov–Galerkin methods for nonlinear systems without monotonicity Original Research Article
120
PETROV-GALERKIN METHODS FOR THE TRANSIENT ADVECTIVE-DIFFUSIVE EQUATION WITH SHARP GRADIENTS
121
Pets and protein: : placing domestic livestock on hobby-farms in England and Wales
122
PETs and their users: a critical review of the potentials and limitations of the privacy as confidentiality paradigm
123
PETs at CSCL Service: Underutilised Potentials for Privacy Enhancing Distance Education
124
Pets, Maternal Sensitization And Continent Of Ancestry Influence Fetal Ige Production
125
Petschek shocks of reconnection for anisotropic pressure Original Research Article
126
PET-SWNT nanocomposites through ultrasound assisted dissolution-evaporation
127
PET-THERAPY: A TRIAL FOR INSTITUTIONALIZED FRAIL ELDERLY PATIENTS
128
Petua dan Pantang Larang Tradisional dalam Alam Melayu Sarawak
129
Peudoexfoliation and poterior capular opacification
130
Peudoexfoliation in a rural population of outhern India: the Aravind Comprehenive Eye urvey
131
Peudoexfoliation yndrome in Autralian adult
132
Peudohypopyon after intravitreal triamcinolone acetonide injection for cytoid macular edema
133
Peudohypopyon of orange pigment overlying a table choroidal nevu
134
Peudomona aeruginoa in vitro corneal iolate enitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative tudy
135
Peudopapilledema in neurofibromatoi type 2
136
Peumusolide A, unprecedented NES non-antagonistic inhibitor for nuclear export of MEK
137
Peut-on évaluer le rôle de la sédimentation sur lʹeffet de serre à lʹéchelle de temps des cycles orbitaux ?
138
Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?
139
Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?
140
Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?
141
Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?
142
PEUTZ JEGHERS SYNDROME PRESENTING WITH ACUTE INTESTINAL OBSTRUCTION: A RARE CASE REPORT WITH REVIEW OF LITERATURES
143
PEUTZ-JEGHER SYNDROME CASE REPORT AND REVIEW OF LITERATURE
144
Peutz-Jeghers Syndrome With Diffuse Gastrointestinal Polyposis: Three Cases in a Family With Different Manifestations and No Evidence of Malignancy During 14 Years Follow Up
145
Peutz-Jeghers syndrome without mucocutaneous pigmentation: a case report
146
Peutz-Jeghers syndrome: 78-year follow-up of the original family
147
PeV cosmic rays: a window on the leptonic era?
148
PeV gamma rays from interactions of ultra high energy cosmic rays in the Milky Way
149
PeV scale Left–Right symmetry and baryon asymmetry of the Universe Original Research Article
150
Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients
151
Peyer’s patch-mediated intestinal immune system modulating activity of pectic-type polysaccharide from peel of Citrus unshiu
152
Peygamberimiz Hz. Muhammed’in Müezzinleri
153
Peykan check, a simple continuous quality control method for hematology analyzers
154
Peyronie’s disease: A contemporary review of non-surgical treatment
155
Peyssonols A and B, Two Novel Inhibitors of the Reverse Transcriptases of Human Immunodeficiency Virus Types 1 and 2
156
PF. Barlett, Editor, Urban Place: Reconnecting with the Natural World, The MIT Press, Cambridge, MA (2005) ISBN 0-262-52443-0 (330pp., $24.00).
157
PF1022A — A novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues
158
PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation
159
PFA — A component in building materials produced from the german plastic packaging waste stream
160
PFA, a Novel Mollusk Agglutinin, Is Structurally Related to the Ribosome-Inactivating Protein Superfamily
161
Pfaffia mosaic virus: a new potyvirus found infecting Pfaffia glomerata in Brazil
162
Pfaffian and Hafnian identities in shuffle algebras
163
Pfaffian decomposition and a Pfaffian analogue of q-Catalan Hankel determinants
164
Pfaffian ideals of ladders Original Research Article
165
Pfaffian Identities: A Combinatorial Approach
166
Pfaffian representation of solutions to a coupled (2 + 1)-dimensional system
167
Pfaffian solution for coupled discrete nonlinear Schrödinger equation
168
Pfaffian solutions for the Manin-Radul-Mathieu SUSY KdV and SUSY sine-Gordon equations
169
Pfaffianization of a -dimensional generalized Kadomtsev–Petviashvili equation
170
Pfaffianization of the two-dimensional Toda lattice
171
Pfaffians and Determinants for SchurQ-Functions
172
Pfaffians, superpotentials and vector bundle moduli
173
Pfaffʹs method (I): The Mills-Robbins-Rumsey determinant Original Research Article
174
Pfaffʹs method (II): diverse applications
175
PFAM catalyzed enantioselective diethylzinc addition to imines
176
Pfanzagl exchanges diagnose an anomaly in expected utility decision theory Original Research Article
177
PFAPA and 12 Common MEFV Gene Mutations Our Clinical Experience
178
PFC full bridge rectifiers EMI modeling and analysis-common mode disturbance reduction
179
PFC Simulation of Brazilian Tensile Strength Test in Geomaterials’ Specimens with T-shaped Non-persistent Joints
180
PFC: A packet forwarding control scheme for vehicle handover over the ITS networks
181
P-FCM: a proximity—based fuzzy clustering
182
P-FCM: a proximity-based fuzzy clustering for user-centered web applications Original Research Article
183
PFCRT and DHFR-TS Sequences for Monitoring Drug Resistance in Adzopé Area of Côte d’Ivoire After the Withdrawal of Chloroquine and Pyrimethamine
184
Pfcrt Gene in Plasmodium falciparum Field Isolates from Muzaffargarh, Pakistan
185
pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective
186
PFEIFFER TYPE I SYNDROME: A GENETICALLY PROVEN CASE REPORT
187
p-FEM applied to finite isotropic hyperelastic bodies Original Research Article
188
p-FEM for finite deformation powder compaction Original Research Article
189
p-FEMs in biomechanics: Bones and arteries
190
PFeW11-doped polymer film modified electrodes and their electrocatalytic activity for H2O2 reduction Original Research Article
191
PFG NMR and internal magnetic field gradients in plant-based materials
192
PFG NMR observation of an extremely strong dependence of the ammonia self-diffusivity on its loading in H-ZSM-5
193
PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands
194
PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands
195
PFG NMR tracer exchange measurements of xenon in zeolites
196
PFGE characterisation and adhesion ability of Listeria monocytogenes isolates obtained from bovine carcasses and beef processing facilities
197
PFGE genotyping and antimicrobial susceptibility of Campylobacter in retail poultry meat in Estonia
198
PFGE genotyping and molecular characterization of Campylobacter spp. isolated from chicken meat
199
PFG-NMR approach to determining the water transport mechanism in polymer electrolyte membranes conditioned at different temperatures
200
PFG-NMR self-diffusion in casein dispersions: Effects of probe size and protein aggregate size
201
PFHC: A clustering algorithm based on data partitioning for unevenly distributed datasets
202
Pfiesteria piscicida and Pfiesteria shumwayae in coastal waters of Long Island, New York, USA
203
Pfiesteria: Harmful Algal Blooms as Indicators of Human: Ecosystem Interactions
204
P-filters and hereditary Baire function spaces
205
P-Filters and the perfect set property
206
p-Filtrations and the Steinberg Module
207
Pfisterʹssubform theorem for reduced special groups
208
Pfizer CEOʹs call to action
209
Pfizer Diflucan Partnership Program
210
Pfizer loses sildenafil case in Australia
211
PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells
212
PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer
213
PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer
214
Pflanzenphysiologie, P. Schopfer, A. Brennicke. Springer Verlag, Berlin, Heidelberg (1999)
215
PF-MPC: Particle filter-model predictive control
216
PfMyb1, a Plasmodium falciparum Transcription Factor, is Required for Intra-erythrocytic Growth and Controls Key Genes for Cell Cycle Regulation Original Research Article
217
PFOS and PFOA in the livers of harbour porpoises (Phocoena phocoena) stranded or bycaught around the UK
218
p-Fractals and power series–I. Some 2 variable results
219
p-Fractals and power series—II.: Some applications to Hilbert–Kunz theory
220
PFS for Mars Express: A new approach to study Martian atmosphere Original Research Article
221
PFS on Mars Express: preparing the analysis of infrared spectra to be measured by the Planetary Fourier Spectrometer
222
PFS/MEX observations of the condensing CO2 south polar cap of Mars
223
PFS: an effective instrument for the study of martian environment Original Research Article
224
PFS-MEX observation of ices in the residual south polar cap of Mars
225
P-functions, Quasi-convex Functions, and Hadamard-type Inequalities1
226
PG 1613+426: A new sdB pulsator
227
PG&E files U.S. suit to halt destec-modesto-praxair deal
228
PG&E proposes its own retail customer accesss
229
PG&E, SCE sell 10,000 MW in plants above book value
230
pg4DB: A fuzzy object-relational system
231
PGA1 and PGA2 are selective ligands for the EP2 and EP4 prostaglandin receptor subtypes
232
PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells
233
PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells
234
PGAMgnam Style: A Glycolytic Switch Controls Biosynthesis
235
PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts
236
PGC1-α mRNA expression cross talk with tumor volume growth and total antioxidant capacity in breast cancer model mice: following discontinuous aerobic exercise and vitamin D intake
237
PGD for aneuploidy screening: an expensive hoax?
238
PGE and Os isotopic analyses of single sample aliquots with NiS fire assay preconcentration
239
PGE and Os-isotopic variations in lavas from Kohala Volcano, Hawaii: Constraints on PGE behavior and melt/crust interaction
240
PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re¯Os and Rb¯Sr isotope study
241
PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re–Os and Rb–Sr isotope study
242
PGE geochemistry and Re–Os dating of massive sulfide ores from the Baimazhai Cu–Ni deposit, Yunnan province, China
243
PGE geochemistry of the Fengshan porphyry–skarn Cu–Mo deposit, Hubei Province, Eastern China
244
PGE mineralization in marginal sulfide ores of the Chineisky layered intrusion, Russia
245
PGE mineralization in the late Archaean iron-rich mafic-ultramafic Hanumalapur Complex, Karnataka, India
246
PGE reefs as an in situ crystallization phenomenon: the Nadezhda gabbronorite body, Lukkulaisvaara layered intrusion, Fennoscandian Shield, Russia
247
PGE Wins Contract to Serve New Palm Springs Muni
248
PGE2 induces oenocytoid cell lysis via a G protein-coupled receptor in the beet armyworm, Spodoptera exigua
249
PGE2 production is suppressed by chemically-synthesized Δ7-eicosatrienoic acid in macrophages through the competitive inhibition of COX-2
250
PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction
251
PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance
252
PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance
253
PGEs and other traffic-related elements in roadside soils from Sa˜o Paulo, Brazil
254
PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity
255
P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil
256
P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).
257
P-glycoprotein activity in renal clear cell carcinoma
258
P-glycoprotein and sister P-glycoprotein sequences from mummichog, Fundulus heteroclitus, liver and intestine
259
P-Glycoprotein expression by human colonic tumor cells influences the growth of tumor cells in vitro
260
P-glycoprotein expression in human major and minor salivary glands
261
P-glycoprotein expression in Perna viridis after exposure to Prorocentrum lima, a dinoflagellate producing DSP toxins
262
P-glycoprotein in autoimmune diseases
263
P-GLYCOPROTEIN IN BLOOD BRAIN BARRIER
264
P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity
265
P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus
266
P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors
267
P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway
268
P-GLYCOPROTEIN QUANTITATION IN ACUTE LEUKEMIA
269
P-glycoprotein: Its role in drug resistance
270
P-Glycoprotein-Mediated Efflux and Drug Sequestration in Lysosomes Confer Advantages of K562 Multidrug Resistance Sublines to Survive Prolonged Exposure to Cytotoxic Agents
271
P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice
272
P-glycoproteins are not released into bile
273
PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II
274
PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II
275
PGO: A parallel computing platform for global optimization based on genetic algorithm
276
Pgp deficiency increases amyloid concetrations in the brain
277
PGP4, an ATP Binding Cassette P-Glycoprotein, Catalyzes Auxin Transport in Arabidopsis thaliana Roots
278
PGPR-induced defense responses in the tea plant against blister blight disease
279
pGPro1, a novel binary vector for monocot promoter characterization
280
PGR5 Is Involved in Cyclic Electron Flow around Photosystem I and Is Essential for Photoprotection in Arabidopsis
281
P-graph methodology for cost-effective reduction of carbon emissions involving fuel cell combined cycles
282
p-groups in the Betti-Mathieu group Original Research Article
283
p-GROUPS OF AUTOMORPHISMS OF ABELIAN p-GROUPS
284
p-Groups of Small Breadth
285
p-GROUPS WITH A SMALL NUMBER OF CHARACTER DEGREES AND THEIR NORMAL SUBGROUPS
286
PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan
287
PGS and the Critical Decision on Transfer of Defective Embryos
288
PGSE diffusion NMR studies on mononuclear and dinuclear cationic platinum salts of (S)-MeO-Biphep and (R)-p-tolyl-BINAP
289
PGSS-drying: Mechanisms and modeling
290
p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation Original Research Article
291
pH – Specific synthesis, spectroscopic, and structural characterization of an assembly of species between Co(II) and N,N-bis(phosphonomethyl)glycine. Gaining insight into metal-ion phosphonate interactions in aqueous Co(II)–organophosphonate systems
292
pH adjustment for seasonal control of UF fouling by natural waters Original Research Article
293
pH Affects the Thermal Inactivation Parameters of R-Phycoerythrin from Porphyra yezoensis
294
pH and biogeochemical processes in the Gotland Basin of the Baltic Sea
295
pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method
296
pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method Original Research Article
297
pH and electro-responsive release behavior of MWCNT/PVA/PAAc composite microcapsules
298
pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin
299
pH and glutathion-responsive hydrogel for localized delivery of paclitaxel
300
pH and grain-size variation in leaching tests with bricks made of harbour sediments compared to commercial bricks
301
pH and heat-induced structural changes of bovine apo-α-lactalbumin
302
pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules
303
pH and ionic strength effect on single fibrinogen molecule adsorption on mica studied with AFM
304
pH- and metal-dependent structural diversity from mononuclear to two-dimensional polymers based on a flexible tricarboxylate ligand
305
pH- and mol-ratio dependent formation of zinc(II) coordination polymers with iminodiacetic acid: Synthesis, spectroscopic, crystal structure and thermal studies
306
pH- and mol-ratio dependent tungsten(VI)–citrate speciation from aqueous solutions: syntheses, spectroscopic properties and crystal structures
307
pH and pCO2 microelectrode measurements and the diffusive behavior of carbon dioxide species in coastal marine sediments
308
pH and redox-responsive mixed micelles for enhanced intracellular drug release
309
pH and salt effects on chiral separations using affinity ultrafiltration Original Research Article
310
pH and salt responsive poly(N,N-dimethylaminoethyl methacrylate) cylindrical brushes and their quaternized derivatives
311
pH and salt-induced reversible aggregation of nonionic synthetic glycolipid vesicles
312
pH and solute concentration of suspension media affect the outcome of high hydrostatic pressure treatment of Listeria monocytogenes
313
pH- and sugar-sensitive layer-by-layer films and microcapsules for drug delivery
314
pH and surface tension dependence of mixed sodium deoxycholate–sodium dehydrocholate pre-micellar aggregation in aqueous solution
315
pH and temperature dependence of particle size in Pb1−xFexS nanoparticle films
316
pH and temperature dependent facile precipitation of nano-goethite particles in Fe(NO3)3–NaOH–NH3NH2HSO4–H2O medium
317
pH and temperature responsive porous membranes via an in situ bulk copolymerization approach
318
pH- and temperature-dependent release from cationic vesicles coexisting with copolymer of N-isopropylacrylamide and methacrylic acid
319
pH- and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization
320
pH- and temperature-responsive hydrogels from crosslinked triblock copolymers prepared via consecutive atom transfer radical polymerizations
321
pH- and temperature-responsive poly(aspartic acid)-l-poly(N-isopropylacrylamide) conetwork hydrogel
322
pH- and temperature-sensitive multiblock copolymer hydrogels composed of poly(ethylene glycol) and poly(amino urethane)
323
pH- and temperature-sensitive permeation through polyelectrolyte complex films composed of chitosan and polyalkyleneoxide–maleic acid copolymer
324
pH- and thermo-multi-responsive fluorescent micelles from block copolymers via reversible addition fragmentation chain transfer (RAFT) polymerization
325
pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies
326
pH- and thermosensitive thin lipid layer coated mesoporous magnetic nanoassemblies as a dual drug delivery system towards thermochemotherapy of cancer
327
pH- and time-dependent hemoglobin transitions: A case study for process modelling Original Research Article
328
p–H and T–S diagrams of 3He from 0.2 K to 20 K Original Research Article
329
pH changes in peralkaline late-magmatic fluids
330
pH changes of self-etching primers mixed with powdered dentine
331
pH control for enhanced reductive bioremediation of chlorinated solvent source zones Original Research Article
332
pH control of the structure, composition, and catalytic activity of sulfated zirconia
333
pH control on oxygen isotopic composition of symbiotic corals
334
pH control strategy in astaxanthin fermentation bioprocess by Xanthophyllomyces dendrorhous
335
pH control strategy of batch microbial transglutaminase production with Streptoverticillium mobaraense
336
pH control: handling nonlinearity and deadtime with fuzzy relational model-based control
337
pH controlled condensation of polysiloxane networks at the water–air interface
338
pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media
339
pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media
340
pH controlled emission of ruthenium(II)–tris–bipyridine complexes
341
pH controlled selective transport of proteins through charged ultrafilter membranes under coupled driving forces: An efficient process for protein separation
342
pH controlled size/shape in CTAB micelles with solubilized polar additives: A viscometry, scattering and spectral evaluation
343
pH controlled supramolecular structures of new silver(I) complexes based on 2-sulfoterephthalic acid and 4,4′-bipyridine
344
pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient
345
pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient
346
pH dependant sticking probability of gold colloid on silicon
347
pH dependence and thermodynamics of Hg(II) adsorption onto chitosan-poly(vinyl alcohol) hydrogel adsorbent
348
pH dependence of electrokinetic behavior of dolomite and magnesite in aqueous electrolyte solutions
349
pH Dependence of ferrous sorption onto two smectite clays
350
pH dependence of heme electrochemistry in cytochromes investigated by multiconformation continuum electrostatic calculations
351
pH Dependence of inhibitors targeting the occluding loop of cathepsin B
352
pH dependence of PDMS–PMAA IPN morphology and transport properties
353
pH Dependence of reactive sites of curcumin possessing antioxidant activity and free radical scavenging ability studied using the electrochemical and ESR techniques: Polyaniline used as a source of the free radical
354
pH dependence of steroid hormone—organic matter interactions at environmental concentrations Original Research Article
355
pH dependence of tailing in reversed-phase chromatography of a cationic dye: measurement of the strong adsorption site surface density
356
pH dependence of the absorption and emission behaviour of lumiflavin in aqueous solution
357
pH dependence of the composition and stability of MnIII–bicarbonate complexes and its implication for redox interaction of MnII with photosystem II
358
pH dependence of the dissociation of multimeric hemoglobin probed by high hydrostatic pressure Original Research Article
359
pH dependence of the fluorescence lifetime of enhanced yellow fluorescent protein in solution and cells
360
pH Dependence of the Folding of Intestinal Fatty Acid Binding Protein
361
pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography
362
pH Dependence of the rate of DNA alkylation for (+)-duocarmycin SA and (+)-CCBI-TMI
363
pH Dependence of the Reaction Rate ofp-Bromophenacyl Bromide and of the Binding Constants of Ca2+and an Amide-Type Substrate Analog to Bovine Pancreatic Phospholipase A2
364
pH dependence of the reactions of arsenazo III with the lanthanides
365
pH dependency of ligand binding to cellobiohydrolase 1 (Cel7A): Affinity, selectivity and inhibition for designed propranolol analogues
366
pH dependency of serum ionised calcium Original Research Article
367
pH dependent binding of chlorin-p6 with phosphatidyl choline liposomes
368
pH Dependent binding of chlorin-p6 with phosphatidyl choline liposomes: Comparison between one and two-photon excited fluorescence
369
pH dependent conformational and structural changes of xylanase from an alkalophilic thermophilic Bacillus sp (NCIM 59)
370
pH dependent copper binding properties of a CuA azurin variant with both bridging cysteines replaced with serines
371
pH dependent dynamic behavior of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in femtosecond to nanosecond time scale
372
pH dependent fluorescence switching in salicylideneaniline: ‘off–on–off’ operation controlled by surfactant micelles
373
pH Dependent formations of dinuclear molybdenum(V) and incomplete cubane molybdenum(IV) complexes with nitrilotriacetate
374
pH dependent growth of poly(L-lysine)/poly(L-glutamic) acid multilayer films and their cell adhesion properties
375
pH dependent interaction of biofunctionalized CdS nanoparticles with nucleobases and nucleotides: A fluorimetric study
376
pH dependent phosphate hydrolysis by a lanthanide EF-hand peptide
377
pH Dependent photophysics and role of medium on photoinduced electron transfer between ruthenium polypyridyl complex and anthraquinone
378
pH dependent protein stability: A quantitative approach based on Kramerʹs barrier escape
379
pH dependent reversible aggregation of Chitosan and glycol-Chitosan stabilized silver nanoparticles
380
pH dependent self assembly of (beta)-amyloid(10-35) and (beta)amyloid(10-35)-PEG3000
381
pH Dependent self-assembly of dimetallic lanthanide complexes
382
pH Dependent structural diversity of lead compounds based on new flexible ligand [3-(2-pyridyl)-1-pyrazolyl] acetic acid
383
pH dependent surface enhanced Raman study of Phe + Ag complex and DFT calculations for spectral analysis
384
pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential
385
PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
386
PH effect in the photocatalytic transformation of a phenyi-urea herbicide
387
pH effect on cysteine and cystine behaviour at hanging mercury drop electrode
388
pH effect on OH radical production in photo/ferrioxalate system
389
pH Effect on the binding of chlorin derivatives with Cremophor EL, a potential drug delivery vehicle
390
pH effect on the electrochemical redox reaction of disulfide with polyaniline film electrode in organic solution
391
pH Effect on the Size of Graphene Quantum dot Synthesized by Using Pulse Laser Irradiation
392
pH Effect on the spectroscopic behavior and photoinduced generation of semiquinone anion radical of hypocrellin B
393
pH effects on collagen fibrillogenesis in vitro: Electrostatic interactions and phosphate binding
394
pH effects on drug interactions with lipid bilayers by liposome electrokinetic chromatography
395
pH effects on optical and DNA binding properties of a thiophene-containing ruthenium(II) complex
396
pH effects on the adherence and fouling propensity of extracellular polymeric substances in a membrane bioreactor
397
pH effects on the binding of oxygen to non-vertebrate monomeric hemoglobins. A linked function model.
398
pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer
399
pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins. Part III. The electrostatic non-specific hyaluronan–hyaluronidase complex
400
pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part II. The electrostatic hyaluronan – Protein complexes
401
pH effects on the second-order nonlinear optical properties of surface modified CdS nanoparticles
402
pH evolution in sea ice grown at an outdoor experimental facility
403
P–H functionalised phosphinoalkoxides as ligands: synthesis and catalytic properties of [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp)-C6H10)] (Tipp=2,4,6-Pri3C6H2), [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp){Mo(CO)5}–C6H10)] and [Cp2Zr(BH4)(cyclo-1-O-2-PH(Mes)(BH3)–C6H10)] (Mes=2
404
pH gradient high-performance liquid chromatography: theory and applications
405
pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides
406
pH has a role in cystic fibrosis infections
407
pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque
408
pH HOMEOSTASIS OF THE CIRCADIAN SPORULATION RHYTHM IN CLOCK MUTANTS OF NEUROSPORA CRASSA
409
pH Independent Complexation of 2-Aminobenzimidazole with β-cyclodextrin
410
pH indications in aqueous organic photodecompositions with carbonyl and hydroxyl groups
411
pH Induced Aggregation and Weak Gel Formation of Whey Protein Polymers
412
pH influence on root growth and nutrient uptake of Pinus pinaster seedlings
413
pH influence on sorption characteristics of heavy metal in the vadose zone
414
pH Influence on the stability of foams with protein–polysaccharide complexes at their interfaces
415
pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils
416
pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils
417
pH measurement and control in solvent extraction using column contractors
418
pH MEASUREMENT USING MICRO GAP STRUCTURE
419
pH Metric, Spectroscopic and Thermodynamic Study of Complexation Behavior of 2-aminobenzothiazole with Ni (II) in Presence of Amino Acids
420
pH microelectrode–micropipette system for the measurement of enzyme reactions in a picoliter volume of a living plant cell Original Research Article
421
pH modelling by neural networks. Application of control and validation data series in the Middle Loire river
422
pH modelling by neural networks. Application of control and validation data series in the Middle Loire river
423
pH Modulates the Quinone Position in the Photosynthetic Reaction Center from Rhodobacter sphaeroides in the Neutral and Charge Separated States
424
pH modulation of transport properties of alamethicin oligomers inserted in zwitterionic-based artificial lipid membranes Original Research Article
425
pH neutralization and influence on mechanical strength in self-adhesive resin luting agents
426
pH of activated carbon surface as an indication of its suitability for H2S removal from moist air streams Original Research Article
427
pH of seawater
428
pH of soul: How does acid-base balance affect our cognition?
429
pH of the Martian surface
430
pH optical sensors based on sol–gels: Chemical doping versus covalent immobilization Original Research Article
431
pH Oscillations and complex reaction dynamics in the non-buffered chlorite–thiourea reaction
432
pH polymeric membrane microelectrodes based on neutral carriers and their application in aquatic environments Original Research Article
433
pH pre-corrected liquid hot water pretreatment on corn stover with high hemicellulose recovery and low inhibitors formation
434
pH programming in capillary electrophoresis by means of temperature programming
435
pH regulates key players of nitrification in paddy soils
436
pH regulates key players of nitrification in paddy soils
437
pH regulation as a method of intensification of soil electroremediation
438
pH regulation during ischaemia-reperfusion of isolated rat hearts, and metabolic effects of 2,3-butanedione monoxime
439
pH Regulation in Anoxic Plants
440
pH regulation of alkaline wastewater with carbon dioxide: A case study of treatment of brewery wastewater in UASB reactor coupled with absorber
441
pH regulation of carbon and nitrogen dynamics in two agricultural soils
442
pH regulation of carbon and nitrogen dynamics in two agricultural soils
443
pH responsive “off–on–off” luminescent switch of a novel ruthenium(II) complex [Ru(bpy)2(pipipH2)]2+
444
pH responsive cross-linked polymeric matrices based on natural polymers: effect of process variables on swelling characterization and drug delivery properties
445
pH responsive itaconic acid grafted alginate microspheres for the controlled release of nifedipine
446
pH responsive luminescent switches of ruthenium(II) complexes containing two imidazole groups: Synthesis, spectroscopy, electrochemistry and theoretical calculations
447
pH Responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier
448
pH responsiveness of two-layer nano-composite membrane with ultrathin cylindrical nanopores PS-b-P4VP film
449
pH sensing in living cells using fluorescent microspheres
450
pH sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery
451
pH Sensitive Hydrogel Based Acrylic Acid for Controlled Drug Release
452
pH Sensitive Hydrogel Based on Poly(Acrylic Acid) and Cellulose Nanocrystals
453
pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery
454
pH sensitive photoconductor based on poly(para-phenylene-vinylene)
455
pH sensitive photoconductor based on poly(para-phenylene-vinylene)
456
pH Sensitive polypropylene porous membrane prepared by grafting acrylic acid in supercritical carbon dioxide
457
pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery
458
pH Sensitive supramolecular assembling system between a new linear water soluble β-cyclodextrin terpolymer and an amphiphilic poly(ethylene oxide)
459
pH sensitivity of polyaniline and its substituted derivatives
460
pH sensor based on a detection sol–gel layer onto optical fiber
461
pH sensor based on deposited film of lead oxide on aluminum substrate electrode
462
pH sensor based on the crown heteropolyanion K28Li5H7P8W48O184·92H2O immobilized using a layer by layer assembly process
463
pH sensors with lithium lanthanum titanate sensitive material: applications in food industry
464
pH sequential ozonation of domestic and wine-distillery wastewaters
465
pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)
466
pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)
467
pH stress can cause cell elongation in Bacillus and Clostridium species: a research note
468
pH Switched sensitisation of europium(III) by a dansyl group
469
pH switching on-off semi-IPN hydrogel based on cross-linked poly(acrylamide-co-acrylic acid) and linear polyallyamine
470
pH transients in hydroxyapatite chromatography columns—Effects of operating conditions and media properties
471
pH Transients in hydroxyapatite chromatography columns—Experimental evidence and phenomenological modeling
472
pH transitions in cation exchange chromatographic columns containing weak acid groups
473
pH Transitions in Ion-Exchange Systems: Role in the Development of a Cation-Exchange Process for a Recombinant Protein
474
pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes
475
pH tunable morphology of the gold nanoparticles produced by citrate reduction
476
pH value and ionic strength effects on the adsorption kinetics of protein/phospholipid at the chloroform/water interface
477
pH Value controlled structures: from macrocyclic complex monomer to 2D macrocyclic sheet
478
pH value dependence of the photothermal and optical absorption spectra for polyaniline films
479
pH variability and CO2 induced acidification in the North Sea
480
pH, alkalinity and total CO2 in coastal seawater by potentiometric titration with a difference derivative readout Original Research Article
481
pH, Dissolved Oxygen, and Adsorption Effects on Metal Removal in Anaerobic Bioreactors
482
pH, Photo, and Aeration Period Effects on Arthrospira maxima Growth: Taguchi Technique
483
pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures
484
Ph.D. in Business Management at Istanbul University: A New Programme in English Ready to Commence in Fall 2016
485
Ph.D. in Nursing from Theory to Reality
486
Ph.D. Students of Irving Segal
487
pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate
488
pH/Temperature control of interpolymer complexation between poly(acrylic acid) and weak polybases in aqueous solutions
489
pH/temperature sensitive poly(ethylene glycol)-based biodegradable polyester block copolymer hydrogels
490
pH/temperature-responsive behaviors of semi-IPN and comb-type graft hydrogels composed of alginate and poly(N-isopropylacrylamide)
491
pH/temperature-sensitive 4-arm poly(ethylene glycol)-poly(amino urethane) copolymer hydrogels
492
Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results
493
Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results
494
Ph3BiCO3: a mild reagent for in situ oxidation of urazoles to triazolinediones
495
Ph3P/Br2/n-Bu4NNO2 as an efficient system for the preparation of N-nitrosamines and azides
496
PHA based denitrification: Municipal wastewater vs. acetate
497
PHA immune response assay in captive zebra finches is modulated by activity prior to testing
498
PHA production by mixed cultures: A way to valorize wastes from pulp industry
499
PHA production from wastewater by mixed microbial culture under short-term microbial enrichment
500
PHA stimulation may be useful for FDXR gene expression-based biodosimetry
501
PHA/IL2: An Efficient Mitogen Cocktail for Cytogenetic Studies of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
502
PHA: A fast potential-based hierarchical agglomerative clustering method
503
PHAC SYNTHASES AND PHA DEPOLYMERASES: THE ENZYMES THAT PRODUCE AND DEGRADE PLASTIC
504
PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations
505
PHACES (Photographs of Academic Clinicians and Their Educational Status): A Tool to Improve Delivery of Family-Centered Care
506
PHACES syndrome with cataract and Horner’s syndrome: a case report
507
Phaco chop: Matering technique, optimizing technology, and avoiding complication
508
Phacodynamic: An Apiration Flow v Vacuum Comparion
509
Phacodynamic: Matering the Tool and Technique of Phacoemulification urgery; Fourth Edition
510
Phacoemulification and len implantation after cleral buckling urgery
511
Phacoemulification Aociated Corneal Damage Evaluated by Corneal Volume
512
Phacoemulification cataract extraction and poterior chamber len implantation in patient with uveiti
513
Phacoemulification of Cataract in Patient Receiving Coumadin Therapy: Ocular and Hematologic Rik Aement Original Reearch Article
514
Phacoemulification v mall-Inciion Manual Cataract urgery: An Expert Trial
515
Phacoemulsification of bilateral cataracts in two pet rabbits
516
Phacomorphic Glaucoma as the First Manifestation of the Choroidal Malignant Melanoma
517
Phacotrabeculectomy and Implantation of Intraocular Lenses with Releasable Sutures and Antimetabolite Agents: Efficacy and Safety
518
Phacotrabeculectomy With Mitomycin C in Patient With Uveiti
519
Phae I/II randomized trial of intrahepatic arterial infuion chemotherapy with ciplatin and chemoembolization with ciplatin and polyvinyl ponge in patient with ocular melanoma metatatic to the liver
520
Phaehyphomycosis caused by Veronea bothryosa
521
Phaeoacremonium tuscanicum, a new fungal pathogen associated with oak decline in Zagros forests, Iran
522
Phaeochromocytoma
523
Phaeochromocytoma—views on current management
524
Phaeocystis blooms in the global ocean and their controlling mechanisms: a review
525
Phaeohyphomycosis caused by Diaporthe phaseolorum in an immunocompetent patient in Thailand: a case report
526
Phaeomoniella chlamydospora: causal agent of vine decline (Vitis vinifera) in the vineyards of Slovakia
527
Phaeophytins from Gossypium mustelinum Miers ex Watt (Malvaceae)
528
Phage adsorption to Lactobacillus plantarum: Influence of physiological and environmental factors
529
Phage coated magnetoelastic micro-biosensors for real-time detection of Bacillus anthracis spores
530
Phage Display and Crystallographic Analysis Reveals Potential Substrate/Binding Site Interactions in the Protein Secretion Chaperone CsaA from Agrobacterium tumefaciens
531
Phage display as a tool for the directed evolution of enzymes
532
Phage display combinatorial libraries of short peptides: ligand selection for protein purification
533
Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope
534
Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope
535
Phage display of functional, full-length human and viral membrane proteins
536
Phage Display Reveals Multiple Contact Sites between FhuA, an Outer Membrane Receptor of Escherichia coli, and TonB
537
Phage Display Screening Reveals an Association Between Germline-specific Transcription Factor Oct-4 and Multiple Cellular Proteins
538
Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites
539
Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites
540
Phage display techniques to obtain antibodies against turbot (Scophthalmus maximus) blood cells
541
Phage display technology for stem cell delivery and systemic therapy
542
Phage display technology: clinical applications and recent innovations
543
Phage FR38 Treatment on Sprague Dawley Rat Inferred from Blood Parameters and Organ Systems
544
Phage Genomics: Small Is Beautiful
545
Phage inactivation of foodborne pathogens on cooked and raw meat
546
Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses
547
Phage Integrases: Biology and Applications Review Article
548
Phage Langmuir monolayers and Langmuir–Blodgett films
549
Phage Like It HOT: Solution Structure of the Bacteriophage P1-Encoded HOT Protein, a Homolog of the θ Subunit of E. coli DNA Polymerase III
550
Phage ø29 DNA polymerase residues involved in the proper stabilisation of the primer-terminus at the 3′-5′ exonuclease active site
551
Phage P22 Procapsids Equilibrate with Free Coat Protein Subunits
552
Phage Peptide Libraries As a Source of Targeted Ligands
553
Phage selection for site-specific incorporation of unnatural amino acids into proteins in vivo Original Research Article
554
Phage Therapy in COVID-19 Treatment
555
Phage therapy: A modern tool to control bacterial infections
556
Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice
557
Phage therapy—advantages over antibiotics?
558
Phage Types of multidrug resistant Salmonella species in a rural area of Maharashtra, India
559
Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru)
560
Phage typing combined with pulsed-field gel electrophoresis and random amplified polymorphic DNA increases discrimination in the epidemiological analysis of Salmonella enteritidis strains
561
Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus
562
Phage versus Phagemid Libraries for Generation of Human Monoclonal Antibodies
563
Phage λ takes the first exit
564
Phage-based nanomaterials for biomedical applications
565
Phage-borne peptidomimetics as immunochemical reagent in dot-immunoassay for mycotoxin zearalenone
566
Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions
567
Phage-displayed peptide library screening for preferred human substrate peptide sequences for transglutaminase 7
568
Phage-displayed peptides that mimic zearalenone and its application in immunoassay
569
Phage-displayed protein chip based on SPR sensing
570
Phagemid Vectors for Phage Display: Properties, Characteristics and Construction Review Article
571
Phage-peptide Display Identifies the Interferon-responsive, Death-activated Protein Kinase Family as a Novel Modifier of MDM2 and p21WAF1
572
Phage-related DNA polymorphism in dairy and probiotic Lactobacillus
573
Phage-resistance linked to cell heterogeneity in the commercial strain Lactobacillus delbrueckii subsp. lactis Ab1
574
Phage-resistant mutants of Lactobacillus delbrueckii may have functional properties that differ from those of parent strains
575
Phagocyte functions in stressed rats: comparison of modulation by glutamine, arginine and ornithine 2-oxoglutarate
576
Phagocyte implications in advanced atherosclerosis
577
Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers
578
Phagocyte-Generated Superoxide Reduces Fe3+ to Displace It from the Surface of Asbestos
579
Phagocyte-induced lipid peroxidation of different intravenous fat emulsions and counteractive effect of vitamin E
580
Phagocyte–myocyte interactions and consequences during hypoxic wound healing
581
Phagocytes and oxidative stress
582
Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules
583
Phagocytic Activity and IL-1 Alpha Levels for Asthma Patients
584
Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent
585
Phagocytic Activity of Patients with a Diabetic Foot in Wasit Province, Iraq
586
Phagocytic activity of scallop (Pecten maximus) haemocytes maintained in vitro
587
Phagocytic activity of turbot (Scophthalmus maximus) leucocytes: opsonic effect of antibody and complement
588
Phagocytic activity of two lines of chickens divergently selected for antibody production
589
Phagocytic activity of two lines of chickens divergently selected for antibody production
590
Phagocytic and chemotactic responses of manila and carpet shell clam haemocytes against Vibrio tapetis, the causative agent of brown ring disease
591
Phagocytic and Metabolic Activities of Macrophages from Mummichog Naturally Exposed to Pulp Mill Effluents in the Miramichi River
592
Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia
593
Phagocytic cells of the thymic reticulum interact with thymocytes via extracellular matrix ligands and receptors
594
Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells
595
Phagocytic killing of microorganisms by radical processes:consequences of the reaction of hydroxyl radicals with chloride yielding chlorine atoms
596
Phagocytic response of macrophages from the pronephros of American plaice (Hipoglossoides platessoides) exposed to contaminated sediments from Baie des Anglais, Quebec
597
Phagocytic Response of Terrestrial and Aquatic Invertebrates Following in Vitro Exposure to Trace Elements
598
Phagocytosis and development: back to the future
599
Phagocytosis and innate immunity
600
Phagocytosis and respiratory burst activity of haemocytes from the ivory snail, Babylonia areolata
601
Phagocytosis by B-cells and neutrophils in Atlantic salmon (Salmo salar L.) and Atlantic cod (Gadus morhua L.)
602
Phagocytosis in pup and adult harbour, grey and harp seals
603
Phagocytosis in pup and adult harbour, grey and harp seals
604
Phagocytosis inhibition of clam and mussel haemocytes by Perkinsus atlanticus secretion products.
605
Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages
606
Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages
607
Phagocytosis of candida albicans by lymphatic tumour cells in vitro
608
Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro
609
Phagocytosis of chemically modified carbon materials
610
Phagocytosis of Loma salmonae (Microsporidia) spores in Atlantic salmon (Salmo salar), a resistant host, and chinook salmon (Oncorhynchus tshawytscha), a susceptible host
611
Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production
612
Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition
613
Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication
614
Phagocytotic removal of apoptotic endocrine cells by folliculostellate cells and its functional implications in clusterin accumulation in pituitary colloids in helmeted guinea fowl (Numida meleagris)
615
Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages
616
Phagotrophic algae in a wastewater stabilization pond
617
PHAHs in 14 principal river sediments from Hai River basin, China Original Research Article
618
Phakic Intraocular Lenses and their Special Indications
619
Phakic IOL: A photo finih?
620
Phakic poterior chamber intraocular len for the correction of aniometropia and treatment of amblyopia
621
Phakomatosis pigmentovascularis type IIa
622
Phalangeal osteochondroma: a cause of childhood trigger finger
623
Phalangeal osteosonogrammetry age-related changes and assessment of a Lebanese reference population
624
Phalangeal Tuberculosis After Mallet Finger Treatment: A Case Report
625
Phalangeal ultrasonography in forearm fracture discrimination
626
Phalanx-like osseous structure posterior to the cervical vertebrae: a hitherto unreported location for a rare anomaly
627
Phalaropes feeding at a coastal front in Santa Monica Bay, California
628
PHALEN TEST POSITIVATION TIME and ITS CORRELATION WITH ELECTRONEUROMYOGRAPHY
629
Phallometric testing with sexual offenders: Limits to its value
630
Phalloplasty for an amputated phallus in intersex patients
631
Phalloplasty in female-to-male transsexuals using free radial osteocutaneous flap: a series of 22 cases, ,
632
Phanerochaete chrysosporium pretreatment of biomass to enhance solvent production in subsequent bacterial solid-substrate cultivation
633
Phanerochaete flavido-alba ligninolytic activities and decolorization of partially bio-depurated paper mill wastes
634
Phanerozoic atmospheric CO2 change: evaluating geochemical and paleobiological approaches
635
Phanerozoic biodiversity: rocks or real?
636
Phanerozoic burial and unroofing history of the western Slave craton and Wopmay orogen from apatite (U–Th)/He thermochronometry
637
Phanerozoic changes in the high-rank suprageneric diversity structure of brachiopods: Linear and non-linear effects
638
Phanerozoic continental growth and gold metallogeny of Asia
639
Phanerozoic Continental Growth of East and Southeast Asia: Timings of Amalgamation and Accretion
640
Phanerozoic Geodynamic Evolution of the Circum-Italian Realm
641
Phanerozoic high-pressure eclogite and intermediate-pressure granulite facies metamorphism in the Gyeonggi Massif, South Korea: Implications for the eastward extension of the Dabie–Sulu continental collision zone
642
Phanerozoic hot spot traces and paleogeographic reconstructions of the Siberian continent based on interaction with the African large low shear velocity province
643
Phanerozoic Large Igneous Provinces (LIPs), HEATT (Haline Euxinic Acidic Thermal Transgression) episodes, and mass extinctions
644
Phanerozoic marine biodiversity follows a hyperbolic trend
645
Phanerozoic organic-carbon-rich marine sediments: Overview and future research challenges
646
Phanerozoic paleogeography, paleoenvironment and lithofacies maps of the circum-Atlantic margins
647
Phanerozoic polar wander, palaeogeography and dynamics
648
Phanerozoic reactivation along a fundamental Proterozoic crustal fault, the Darling River Lineament, Australia: constraints from apatite fission track thermochronology
649
Phanerozoic reactivation of the Archean North China Craton through episodic magmatism: Evidence from zircon U–Pb geochronology and Hf isotopes from the Liaodong Peninsula
650
Phanerozoic Reconstitution of Indian Shield as Aftermath of Gondwana Break-up
651
Phanerozoic tectonics of the South China Block: Key observations and controversies
652
Phanerozoic tectonothermal events of the Xuefengshan Belt, central South China: Implications from UPb age and LuHf determinations of granites
653
Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology
654
Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology
655
Phanquinone: a useful fluorescent pre-chromatographic derivatization reagent for liquid chromatographic analyses of amino acid dosage forms Original Research Article
656
PHANTASTICA Regulates Development of the Adaxial Mesophyll in Nicotiana Leaves
657
Phantom accretion by black holes and the generalized second law of thermodynamics
658
Phantom and in vivo study of the look–locher T1 mapping method
659
Phantom Archean crust in Mangaia hotspot lavas and the meaning of heterogeneous mantle
660
Phantom bursting is highly sensitive to noise and unlikely to account for slow bursting in -cells: Considerations in favor of metabolically driven oscillations
661
Phantom dosimeters examined by NMR analysis: a promising technique for 3-D determination of absorbed dose
662
Phantom elasticity reconstruction with Digital Image Elasto-Tomography
663
Phantom endometriosis of the sciatic nerve
664
Phantom evolution in power-law potentials Original Research Article
665
Phantom faces for face analysis
666
Phantom feelings in the thalamus explained
667
Phantom Friedmann cosmologies and higher-order characteristics of expansion
668
Phantom limb after stroke: An underreported phenomenon
669
Phantom limb pain
670
Phantom limb pain
671
Phantom limb pain in pediatric burn survivors
672
Phantom Limb Sensation (PLS) and Phantom Limb Pain (PLP) among Young Landmine Amputees
673
PHANTOM LIMB SYNDROME: A REVIEW
674
Phantom limbs – Or phantoms of phantom limbs?
675
Phantom maps and homology theories
676
Phantom Maps and Purity in Modular Representation Theory, III
677
Phantom maps and the Gray index
678
Phantom Maps in the Stable Module Category
679
Phantom materials for single point imaging pulse sequences
680
Phantom nurses at real bedsides
681
Phantom recall
682
Phantom reflexes: Muscle contractions at a frequency not physically present in the input stimuli
683
Phantom study of radiotracer concentration quantification in breast scintigraphy
684
Phantom thermodynamics Original Research Article
685
Phantom tumor of the lung in heart failure patient
686
Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device
687
PHANTOM: A Monte Carlo event generator for six parton final states at high energy colliders Original Research Article
688
Phantom: a simple and effective flow control scheme
689
Phantom-based performance evaluation: Application to brain segmentation from magnetic resonance images
690
Phantom-like behaviour in dilatonic brane-world scenario with induced gravity Original Research Article
691
Phantom-limb lengthening after heart transplant
692
Phantom-limb pain: characteristics, causes, and treatment
693
Phantom-node method for shell models with arbitrary cracks
694
Phantoms and spectres: capital and labour at the millennium
695
Phantoms of regularity in the sea of quantum chaos
696
PhAP protease from Pseudoalteromonas haloplanktis TAC125: Gene cloning, recombinant production in E. coli and enzyme characterization
697
Phar Lap and duodenitis-proximal jejunitis
698
Pharaoh and the Divine Wont of Respiting: A Critical Analysis of Quranic Themes
699
PHARAOH EAGLE-OWL BUBO ASCALAPHUS (SAVIGNY, 1809) (STRIGIFORMES, STRIGIDAE), THE “SHROUDED IN MYSTERY” OWL OF IRAQ and IRAN
700
Pharmaceutical Advances and Proteomics Researches
701
Pharmaceutical advertising versus research spending: are profits more important than patients?
702
Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues
703
Pharmaceutical Analysis, D.C. Lee, M. Webb (Eds.). Blackwell Publishing Ltd, Oxford, UK (2003)
704
Pharmaceutical and Bio-analytical Applications of Ion Mobility Spectrometry for Determination of Clopidogrel (Plavix)
705
Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy
706
Pharmaceutical and clinical aspects of p-phenylene-diamine patch test material
707
PHARMACEUTICAL AND CLINICAL EVALUATION OF INTRAVENOUS ADMIXTURE OF DOBUTAMINE AND DOPAMINE USED IN TREATMENT HYPOTENSION IN NEONATAL INTENSIVE CARE UNITS
708
Pharmaceutical and industrial protein engineering: Where we are?
709
Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract
710
Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives
711
Pharmaceutical and personal care products (PPCPs) in urban receiving waters l
712
Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field Original Research Article
713
Pharmaceutical and Related Drugs
714
Pharmaceutical applications of a flurbiprofen sensor
715
Pharmaceutical applications of calorimetric measurements in the new millennium
716
Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems
717
Pharmaceutical applications of dynamic mechanical thermal analysis
718
Pharmaceutical applications of embryonic stem cells
719
Pharmaceutical applications of isoelectric focusing on microchip with imaged UV detection
720
Pharmaceutical applications of magnetic resonance imaging (MRI)
721
Pharmaceutical applications of Mid-IR and Raman spectroscopy
722
Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies
723
Pharmaceutical applications of various natural gums, mucilages and their modified forms
724
Pharmaceutical Approaches and Advancements in Male Contraception
725
Pharmaceutical aspects of parenteral nutrition: from now to the future
726
Pharmaceutical Care Approach to Hearing Loss
727
Pharmaceutical Care Education and Practice in Jordan in the New Millennium
728
Pharmaceutical care impact on health-related quality of life (HRQOL) and pharmaco-economical burden on COVID recovered diabetic patients with comorbid condition
729
Pharmaceutical Care Program for Patients With Uncontrolled Hypertension: Report of a Double-Blind Clinical Trial With Ambulatory Blood Pressure Monitoring
730
Pharmaceutical challenges in veterinary product development
731
Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model
732
Pharmaceutical Characterization of Aqueous Stem Bark Extract of Bridelia ferruginea Benth (Euphorbiaceae)
733
Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment
734
Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation
735
Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications
736
Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development
737
Pharmaceutical companies and the third world
738
Pharmaceutical companies pay criminal fine for fxobal price fixing
739
Pharmaceutical companies pledge vaccines for developing countries
740
Pharmaceutical companies target plant products for drugs of the future
741
Pharmaceutical company trials and the integrity of medical research
742
Pharmaceutical Compounds as Photostabilizers
743
Pharmaceutical cost management and access to psychotropic drugs: The U.S. context
744
Pharmaceutical economy and the economic assessment of drugs in France
745
Pharmaceutical Electrochemistry: the Electrochemical Behaviour of Paracetamol at ZnO Nanoparticales/1, 2-Napthaquinone-4-Sulphonic Acid Glassy Carbon Modified Electrode
746
Pharmaceutical Equivalence of Some Commercial Samples of Artesunate and Amodiaquine Tablets Sold in Southwestern Nigeria
747
Pharmaceutical Evaluation of Metformin HCl Products Available in the Jordanian Market
748
Pharmaceutical Evaluation of Ziziphus Jujuba Mucoadhesive Buccal Film
749
Pharmaceutical Excipient Development: The Need for Preclinical Guidance
750
Pharmaceutical Formulation of Garlic and Turmeric Dried Crude Extract and Their Synergistic Antifungal Activity and Safety
751
Pharmaceutical haute couture: educating patients about health-care choices
752
Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives
753
Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications
754
Pharmaceutical industry profits and cost to senior citizensʹ health
755
Pharmaceutical Industry Roundtable Abstracts
756
Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009
757
Pharmaceutical laws and regulations in Iran: An overview
758
Pharmaceutical microcalorimetry: recent advances in the study of solid state materials
759
Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications
760
Pharmaceutical Nanoparticles and the Mucin Biopolymer Barrier
761
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
762
Pharmaceutical Nickel(II) Chelation Properties of 3-Hydroxyflaven, Deferiprone and Maltol Metal Chelators: A Density Functional Study
763
Pharmaceutical patent analyst – FutureScience publishing
764
Pharmaceutical patents on plant derived materials in Brazil: Policy, law and statistics
765
Pharmaceutical policies used by private health insurance companies in Saudi Arabia
766
Pharmaceutical powder technology — from art to science: the challenge of the FDAʹs Process Analytical Technology initiative
767
Pharmaceutical powders analysis using FT-Raman spectrometry: Simultaneous determination of sulfathiazole and sulfanilamide
768
Pharmaceutical powders compaction: Experimental and numerical analysis of the density distribution
769
pharmaceutical prescription (Rx): Calcium, phosphate, and secundum artem
770
Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography–mass spectrometry
771
Pharmaceutical Properties of Hibiscus sabdariffa, Toward an Ideal Treatment for Hypertension
772
Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing
773
Pharmaceutical representatives
774
Pharmaceutical representatives’ beliefs and practices about their professional practice: a study in Sudan
775
Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck
776
Pharmaceutical research: paradox, challenge or dilemma?
777
Pharmaceutical risk management in Turkey: The first national overview
778
Pharmaceutical Statistics Using SAS®: A Practical Guide by Alex Dmitrienko, Christy Chuang-Stein, Ralph DʹAgostino
779
Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors
780
Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines
781
Pharmaceutical supply chain risks: a systematic review
782
Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation
783
Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography–ion trap tandem mass spectrometry
784
Pharmaceutical Wastewater Chemical Oxygen Demand Reduction: Electro-Fenton, UV-enhanced Electro-Fenton and Activated Sludge
785
Pharmaceutical wastewater treatment by membrane bioreactor process – a case study in southern Taiwan Original Research Article
786
Pharmaceutical workers
787
PHARMACEUTICAL, FOOD AND NON-FOOD APPLICATIONS OF MODIFIED STARCHES: A CRITICAL REVIEW
788
Pharmaceutical-enantiomers resolution using immobilized polysaccharide-based chiral stationary phases in supercritical fluid chromatography
789
Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA
790
Pharmaceuticals and personal care products (PPCPs) in foods. Potential risks to human health?
791
Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada
792
Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina Original Research Article
793
Pharmaceuticals and the Strategic National Stockpile Program
794
Pharmaceuticals in Australia: developments in regulation and governance
795
Pharmaceuticals in groundwaters: Analytical methods and results of a monitoring program in Baden-Württemberg, Germany
796
PHARMACEUTICALS IN IRAN: AN OVERVIEW
797
Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment
798
Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies
799
Pharmaceuticals in the river Elbe and its tributaries
800
Pharmaceuticals Safety Practices-A Comparative Pilot Study
801
Pharmaceuticals Solubility is Still Nowadays Widely Studied Everywhere
802
Pharmaceuticals, alkylphenols and pesticides in Mediterranean coastal waters: Results from a pilot survey using passive samplers
803
Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada — Occurrence and treatment efficiency Original Research Article
804
Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system Original Research Article
805
Pharmaceuticals: a threat to drinking water? Original Research Article
806
Pharmaceuticals—our true clinical partners?
807
Pharmaciesʹ over-the-counter drug monopoly in Denmark ended
808
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India
809
Pharmacist and nurse: a team approach towards primary health care or a convenient “therapeutic alliance”? Original Research Article
810
Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach
811
PHARMACIST ROLE IN GLOBAL HEALTH: A REVIEW OF LITERATURE
812
Pharmacist, the pharmaceutical industry and pharmacy education in Saudi Arabia: A questionnaire-based study
813
Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process
814
Pharmacist-Led Medication Review: Supports for New Role of Pharmacists
815
PHARMACIST-MANAGED THERAPEUTIC DRUG MONITORING SERVICE FOR ANTIEPILEPTIC DRUGS AND IMPROVED SEIZURE CONTROL
816
Pharmacist-Physician Organic Cooperation Is an Effective Strategy to Reduce the Medication-related Problems, An Experience in CKD Patients
817
Pharmacists agree: stop the pharmacy madness
818
Pharmacists as Entrepreneurs or Employees: The Role of Locus of Control
819
Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
820
PHARMACISTS UNDERSTANDING AND ATTITUDES TOWARDS PHARMACEUTICAL CARE IN SAUDI ARABIA
821
Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study
822
Pharmacists’ Attitudes and Perceived Barriers about Community Pharmacy-Based Cardiovascular Risk Screening Services
823
PHARMACISTS’ NEGLIGENCE AND PRINCIPLES OF LIABILITY
824
Pharmacists’ Perception of the Sale of Non-Clinically Proven Health Supplements in Penang, Malaysia
825
Pharmaco1logic Evaluation of the Calcitonin Analogue SB 205614 in Models of Osteoclastic Bone Resorption In Vitro and In Vhro: Comparison With Salmon Calcitonin and Elcatonin
826
Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days
827
Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: An isobolographic analysis
828
Pharmacodynamic Effect of N-Acetylcysteine as Adjunctive Therapy in Mild Systemic Lupus Erythematosus Patients
829
Pharmacodynamic effects of milrinone with and without a bolus loading infusion
830
Pharmacodynamic Effects of Prasugrel Dosing Regimens in Patients on Maintenance Prasugrel Therapy: Results of a Prospective Randomized Study
831
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)
832
PHARMACODYNAMIC INTERACTION OF GARLIC WITH PROPRANOLOL IN ISCHEMIA-REPERFUSION INDUCED MYOCARDIAL DAMAGE
833
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects Original Research Article
834
Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro
835
Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects
836
Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide
837
Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae
838
Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats
839
Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models
840
Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection
841
Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration
842
Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration
843
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of ilgrastim
844
Pharmacodynamics in the elderly
845
Pharmacodynamics of alpha2-adrenoceptor agonists
846
Pharmacodynamics of antimicrobial therapy in surgery
847
Pharmacodynamics of immunosuppressive drugs
848
Pharmacodynamics of Intermittent- and Continuous-Infusion Gefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model
849
Pharmacodynamics of mivacurium in severely burned patients
850
Pharmacodynamics of warfarin in cats
851
Pharmacodynamics Studies on Ricobendazole In Male Rats
852
Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia
853
Pharmacodynamics: Relation to antimicrobial resistance
854
Pharmacodynamics: Relation to Antimicrobial Resistance
855
Pharmacoeconomic Aspects of Treating Hemorrhoidal Disease-Cost of Illness Study Based on Data from Balkan Country with Recent History of Social and Economic Transition
856
Pharmacoeconomic assessment of midazolam in two emergency departments
857
Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina
858
Pharmacoeconomic Evaluation of Anti-Diabetic Therapy in A Nigerian Tertiary Health Institution
859
Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes
860
Pharmacoeconomic Impact Evaluation of Statin Adherence in High-risk Unselected Post Myocardial Infarction Population: an Administrative Database-guided Analysis
861
Pharmaco-economic issues for diabetes therapy
862
Pharmacoeconomic issues in antihypertensive therapy
863
Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital
864
Pharmacoeconomics Analysis in a Pediatric Population
865
Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system
866
Pharmacoeconomics and health outcomes: state of the art
867
Pharmacoeconomics and Utilization of Intravenous Iron Sucrose in a Tertiary Care Hospital
868
Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital
869
Pharmacoeconomics for surgeons
870
Pharmacoeconomics in Iran: It Is Time to Take It into Practice
871
Pharmacoeconomics of Angiotensin Converting Enzyme Inhibitors in Heart Failure
872
PHARMACO-ECONOMICS OF MICRODOSING CLINICAL TRIALS IN DRUG DEVELOPMENT PROCESS
873
Pharmacoeconomics of pneumonia
874
Pharmacoeconomics: what is it and where is it going?
875
Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?
876
Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam
877
Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt
878
Pharmacoepidemiology of Drugs Used in Indoor Patients of Orthopaedic Department at a Tertiary Care Hospital
879
Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy
880
Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients
881
Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure Original Research Article
882
Pharmacogenetic prediction of clozapine response Original Research Article
883
Pharmacogenetic Studies of Depression
884
Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation
885
Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients
886
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs
887
Pharmacogenetics and adverse drug reactions
888
Pharmacogenetics and antipsychotic drugs
889
Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
890
Pharmacogenetics and future drug development and delivery
891
Pharmacogenetics and Personalized Medicine in Pancreatic Cancer
892
Pharmacogenetics draws an ACE
893
Pharmacogenetics in Cardiovascular Antithrombotic Therapy
894
Pharmacogenetics of anti-estrogen treatment of breast cancer
895
Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine
896
Pharmacogenetics of clozapine response
897
Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances
898
Pharmacogenetics of disease-modifying anti-rheumatic drugs
899
Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management
900
Pharmacogenetics of inflammatory bowel disease
901
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother
902
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
903
Pharmacogenetics, the Promise of Translating Personalized Medicine into Clinical Pediatrics
904
Pharmacogenetics: Fitting the Drug to the Patient
905
Pharmacogenetics: Is the right drug for the right patient sufficient?
906
Pharmacogenetics: Yeast Lead the Way
907
Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients
908
Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients
909
Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen
910
Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives
911
Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy
912
Pharmacogenomic Profiling of the PI3K/PTEN Pathway in Sporadic Breast Cancer
913
Pharmacogenomics and -genetics in colorectal cancer
914
Pharmacogenomics and the Failing Heart: Are We Waiting for Godot?
915
Pharmacogenomics for Infectious Diseases
916
pharmacogenomics implementation and hurdles to overcome; in the context of a developing country
917
Pharmacogenomics in bladder cancer
918
Pharmacogenomics in bladder cancer
919
Pharmacogenomics in Cancer Chemotherapy
920
Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone
921
Pharmacogenomics in non-small-cell lung cancer chemotherapy
922
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
923
Pharmacogenomics- The Promise of Personalized Medicine
924
Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs
925
Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs
926
Pharmacogenomics: out of the lab and into the community
927
Pharmacognostic and Acute Toxicity Study of Burkea Africana Root
928
Pharmacognostic and AntiInflammatory Properties of Securigera securidaca Seeds and Seed Oil
929
Pharmacognostic and Elemental Analysis of the Leaves of Tapinanthus globifer (A. Rich). Tiegh
930
Pharmacognostic and Physico-chemical Investigation of Barleria cristata Linn. (Leaf) for Quality Control Assessment
931
Pharmacognostic and phytochemical investigation of Heracleum persicum Desf. ex Fischer
932
Pharmacognostic and Preliminary Phytochemical Investigation on Doronicum scorpioides Roots
933
Pharmacognostic Characteristics and Mutagenic Studies of Alstonia boonei De Wild
934
Pharmacognostic Characteristics of Hibiscus sabdariffa L. as a Means of Monitoring Quality
935
Pharmacognostic evaluation and physico-chemical analysis of Lantana camara (Linn.) flowers
936
Pharmacognostic evaluation of Achyranthes coynei: Leaf
937
Pharmacognostic Evaluation of Maesobotrya barteri (Baill) Hutch and Maesobotrya dusenii Pax (Euphorbiaceae) Leaves
938
Pharmacognostic Evaluation of Oxalis pes-caprae L. (Family Oxalidaceae)
939
Pharmacognostic evaluation of the leaves of Mitracarpus scaber Zucc (Rubiaceae)
940
Pharmacognostic Evaluation of the Leaves of Secamone afzelii (Schult) K Schum (Asclepiadaceae)
941
Pharmacognostic Investigation of the Leaves and Stems of Viburnum erubescens Wall.ex DC
942
Pharmacognostic Profile and Screening of Anti-Proliferative Potential of Methanolic Extract of Tripterygium wilfordii Plant on WRL-68 Cell Line and Function of Polycystin‐1
943
Pharmacognostic Standardization and Chromatographic Fingerprint Analysis on Triterpenoidal Constituents of the Medicinally Important Plant Artocarpus heterophyllus by High‑Performance Thin Layer Chromatography Technique
944
Pharmacognostic study of Argyreia pilosa stem
945
Pharmacognostic, Physicochemical and Phytochemical Investigations on Aerial Parts of Argemone mexicana L.
946
Pharmacognostical and physico-chemical evaluations of Cardiospermum halicacabum L. seeds
947
Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease
948
Pharmacognostical study of Chorisia insignis HBK. grown in Egypt
949
Pharmacognostical, physico-chemical and contamination studies of polyherbal formulation “qurse pudina”
950
Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse
951
Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice
952
Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography
953
Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging
954
Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers
955
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
956
Pharmacokinetic and drug interaction studies of Pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan
957
Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC–MS/MS after oral administration of the Swertia pseudochinensis extract
958
Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques, ,
959
Pharmacokinetic and Hemodynamic Responses to Oral Sildenafil During Invasive Testing in Children With Pulmonary Hypertension
960
Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats
961
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part 1. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers
962
Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Doseproportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers
963
Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension
964
Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida
965
Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats
966
Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation
967
Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article.
968
Pharmacokinetic and tissue distribution of doxycycline in broiler chickens pretreated with either: Diclazuril or halofuginone
969
Pharmacokinetic and toxicological data of spirolides after oral and intraperitoneal administration
970
Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative
971
Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats
972
Pharmacokinetic application of fuzzy structure identification and reasoning
973
Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats
974
Pharmacokinetic behavior of marbofloxacin after intravenous, subcutaneous and intramuscular administrations in llamas (Lama glama)
975
Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population
976
Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury
977
Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration
978
Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration
979
Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs
980
Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: Simultaneous determination of ten active constituents by HPLC–MS/MS
981
Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica
982
Pharmacokinetic Computer Simulations of the Relationship Between In Vivo and In Vitro Neuroreceptor Subtype Selectivity of Radioligands
983
Pharmacokinetic considerations for targeted drug delivery
984
Pharmacokinetic differences between ethnic groups
985
Pharmacokinetic differences between ethnic groups
986
Pharmacokinetic dosing of aminoglycosides: a controlled trial
987
Pharmacokinetic Drug Food Interaction Study of Nateglinide and Pomegranate Fruit Juice
988
Pharmacokinetic drug‑drug interaction and their implication in clinical management
989
Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia
990
Pharmacokinetic enhancement of marbofloxacin by alpha-1-monolaurin pre-treatment in broiler chickens
991
PHARMACOKINETIC EVALUATION OF CLARITHROMYCIN ORAL CONTROLLED RELEASE MATRIX TABLETS FOR DESIRED BIOAVAILABILITY AND IMPROVED PATIENT COMPLIANCE
992
Pharmacokinetic evaluation of dipfluzine and its three metabolites in rat plasma using liquid chromatography–mass spectrometry
993
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
994
Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study
995
Pharmacokinetic Evaluation of Two Doses of Aminophylline/Theophylline Administered as Multiple Intermittent Infusions to Iranian Apneic Premature Neonates
996
Pharmacokinetic Interaction of Salbutamol Coadministered with Vasicine Isolated from Adhathoda vasica on Rabbit
997
Pharmacokinetic Interaction Study for Simvastatin and Parsley and Its Plasma Quantification Using LC-MS: A Focus on Drug Metabolic Enzymes
998
Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda
999
Pharmacokinetic Interactions between Intravenous Ciprofloxacin and Oral Ferrous Sulfate
1000
Pharmacokinetic interactions: The effects of selected herbal extracts on permeation of P-glycoprotein substrate drugs across excised pig intestinal tissue
